These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8601933)

  • 21. Nephrology and the rationing of health care.
    Friedman EA
    Contrib Nephrol; 1993; 102():220-36. PubMed ID: 8416184
    [No Abstract]   [Full Text] [Related]  

  • 22. HCFA: failing to acknowledge the unique characteristics of the ESRD patient.
    Kanter A; Nidetz M
    Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135
    [No Abstract]   [Full Text] [Related]  

  • 23. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic kidney disease: the distribution of health care dollars.
    St Peter WL; Khan SS; Ebben JP; Pereira BJ; Collins AJ
    Kidney Int; 2004 Jul; 66(1):313-21. PubMed ID: 15200439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Medicare end-stage renal disease program. A report from the Institute of Medicine.
    Levinsky NG; Rettig RA
    N Engl J Med; 1991 Apr; 324(16):1143-8. PubMed ID: 2008193
    [No Abstract]   [Full Text] [Related]  

  • 27. Rationing of health care and the end-stage renal disease program.
    Klahr S
    Am J Kidney Dis; 1990 Oct; 16(4):392-5. PubMed ID: 2220792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health care provision and distributive justice: end stage renal disease and the elderly in Britain and America.
    Gill DG; Ingman SR; Campbell J
    Soc Sci Med; 1991; 32(5):565-77. PubMed ID: 2017725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 30. Providers skittish about Medicare kidney-care ACO initiative.
    Rice S
    Mod Healthc; 2014 Sep; 44(35):10. PubMed ID: 25318272
    [No Abstract]   [Full Text] [Related]  

  • 31. The coming fiscal crisis: nephrology in the line of fire.
    Andersen MJ; Friedman AN
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1252-7. PubMed ID: 23704301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy and research in end-stage renal disease.
    Jones KR
    Image J Nurs Sch; 1987; 19(3):126-9. PubMed ID: 3117675
    [No Abstract]   [Full Text] [Related]  

  • 33. Medicare program; standards for quality of water used in dialysis and revised guidelines on reuse of hemodialysis filters for end-stage renal disease (ESRD) patients--HCFA. Final rule.
    Fed Regist; 1995 Sep; 60(180):48039-44. PubMed ID: 10151653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare's End-Stage Renal Disease Program: its development and implications for health care policy.
    Southern HB
    Harvard J Legis; 1989; 26(1):225-62. PubMed ID: 11659153
    [No Abstract]   [Full Text] [Related]  

  • 36. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of services in managed care: guidelines for use of renal dialysis.
    Paris JJ; Moss AH
    Trends Health Care Law Ethics; 1995; 10(1-2):101-4. PubMed ID: 7655217
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the ESRD managed care demonstration operations.
    Oppenheimer CC; Shapiro JR; Beronja N; Dykstra DM; Gaylin DS; Held PJ; Rubin RJ
    Health Care Financ Rev; 2003; 24(4):7-29. PubMed ID: 14628397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The politics of health cost containment: end-stage renal disease.
    Rettig RA
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract]   [Full Text] [Related]  

  • 40. Decrease the increase.
    Prather E
    Tex Med; 2006 Jun; 102(6):31-4. PubMed ID: 17115573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.